Thyroid Cancer News and Research

Latest Thyroid Cancer News and Research

EpiCept reports net loss of $5.4 million for third quarter 2011

EpiCept Corporation today announced operating and financial results for the three and nine months ended September 30, 2011, and provided an update with respect to the Company's key business initiatives.

8 Nov 2011

Study: Melanoma survivors more likely to have new cancers

Melanoma skin cancer survivors are much more likely than the general population to have future new cases of invasive melanomas and other cancers, says a national study led by UAMS' Appathurai Balamurugan, M.D., M.P.H.

3 Nov 2011

Prescription drug shortages: Endocrine Society calls for mandatory reporting by manufacturers

The Executive Order President Obama issued Monday directing the U.S. Food and Drug Administration to take action to reduce prescription drug shortages is a commendable first step, but the White House could strengthen its directive and address the full scope of the problem by ordering mandatory reporting by manufacturers, which The Endocrine Society calls for in its Position Statement on drug shortages.

2 Nov 2011

BUSM professor delivers Van Meter Award Lecture at 81st ATA meeting

The American Thyroid Association (ATA) is proud to announce that Dr. Elizabeth Pearce, Associate Professor of Medicine at Boston University School of Medicine, today delivered the Van Meter Award Lecture at its 81st Annual Meeting, held October 26-30, Indian Wells, California.

1 Nov 2011

Glitazone treatment does not cause side effects in patients with metastatic thyroid cancer

Repeated radio-ablation therapy with iodine-131 to treat metastatic thyroid cancer can be less effective than the initial round of treatment due to de-differentiation of the cancer cells as the disease progresses, making them less sensitive to I-131.

29 Oct 2011

Thyroid researcher to receive ATA's John B. Stanbury Pathophysiology Medal

Each year, the American Thyroid Association (ATA) recognizes the outstanding research contributions of one of its members to a greater understanding of thyroid physiology or the pathophysiology of thyroid disease, with its presentation of the John B. Stanbury Pathophysiology Medal at its Annual Meeting.

29 Oct 2011

Thyroidectomy reduces snoring associated with obstructive sleep apnea

Obstructive sleep apnea, caused by narrowing or blockage of the airways when a person is asleep affects about 20% of the population. Typically a person with OSA will begin snoring loudly on falling asleep. If not treated, obstructive sleep apnea (OSA) can increase a person's risk of death. It is not clear whether an enlarged thyroid gland, known as a goiter, can worsen cause or worsen symptoms of OSA by compressing the airway.

29 Oct 2011

Researchers explore novel therapeutic approach for thyroid cancer

Some forms of differentiated thyroid cancer (DTC) respond to treatment with radioactive iodine, which is taken up by the thyroid gland, destroying the cancerous cells. However patients with two forms of thyroid cancer, radioiodine-refractory DTC and anaplastic thyroid cancer (ATC), do not benefit from radioiodine therapy, and other treatment options are limited.

28 Oct 2011

UCLA professor to receive ATA's Sidney H. Ingbar Distinguished Lectureship Award

The American Thyroid Association's (ATA) Sidney H. Ingbar Distinguished Lectureship Award recognizes outstanding academic achievements in thyroidology. An honorarium is conferred each year at the ATA Annual Meeting to an established investigator who has made major contributions to thyroid-related research over many years.

28 Oct 2011

New rapid method for detection of BRAF V600E gene in thyroid tissue

During surgical removal of thyroid tissue suspicious for cancer, fast, reliable, and cost-effective techniques are needed to analyze the resected tissue for biomarkers—including BRAF V600E, is a molecular biomarker for papillary thyroid cancer (PTC)—that can confirm the presence and type of cancer cells. Researchers have developed a new, rapid method for direct detection of the BRAF V600E gene in thyroid tissue without the need to purify DNA from tumor cells—high resolution melting analysis.

28 Oct 2011

ATA to honor 2011 recipient of Lewis E. Braverman Lectureship Award on Oct. 29

The American Thyroid Association's (ATA) Lewis E. Braverman Lectureship Award recognizes a member of the ATA who has demonstrated excellence and passion for mentoring fellows, students, and junior faculty and has a long history of productive thyroid research.

28 Oct 2011

Advanced papillary thyroid cancer patients with BRAFV600E gene mutation at higher risk

Individuals with advanced papillary thyroid cancer (PTC) that are associated with the BRAFV600E gene mutation have a higher risk of recurrent disease and progression to more advanced, poorly differentiated thyroid cancer, according to data presented today at the 81st Annual Meeting of the American Thyroid Association (ATA).

28 Oct 2011

Lenvatinib may achieve partial response in thyroid, endometrial, and renal cancers

Phase 1 clinical studies of the experimental anticancer drug lenvatinib indicate that it may achieve at least a partial response in thyroid, endometrial, and renal cancers and melanoma.

28 Oct 2011

Top-line results from Exelixis' cabozantinib phase 3 trial on medullary thyroid cancer

Exelixis, Inc. today reported top-line results from the ongoing phase 3 clinical trial of cabozantinib in patients with advanced medullary thyroid cancer (MTC), known as the EXAM trial.

24 Oct 2011

MD Anderson professor wins 2011 Julie and Ben Rogers Award for Excellence in Prevention

Lorna McNeill, Ph.D., assistant professor in the Department of Health Disparities Research at The University of Texas MD Anderson Cancer Center, is the recipient of the 2011 Julie and Ben Rogers Award for Excellence in Prevention.

22 Sep 2011

Two newer Type 2 diabetes drugs could be linked to increased risk of pancreatic cancer

Two newer drugs used to treat Type 2 diabetes could be linked to a significantly increased risk of developing pancreatitis and pancreatic cancer, and one could also be linked to an increased risk of thyroid cancer, according to a new UCLA study.

19 Sep 2011

New diabetes drugs linked to increased risk of pancreatitis and pancreatic cancer

17 Sep 2011

ATA announces five recipients of 2011 thyroid cancer research grants

The American Thyroid Association (ATA) announced the five recipients of its 2011 research grants, each of whom will receive up to $25,000 annually for up to two years. Three of the five recipients were awarded special ATA ThyCa grants for research projects that focus on thyroid cancer. These grants are funded by ThyCa: Thyroid Cancer Survivors, Inc.

8 Sep 2011

Unexplained hospital factors have impact on radioactive iodine use for thyroid cancer: Study

Where thyroid cancer patients go for care plays a large role in whether they receive radioactive iodine treatment, a new study from the University of Michigan Comprehensive Cancer Center finds.

18 Aug 2011

Radioiodine being overused in thyroid cancer: Study

According to the latest research the use of radioactive iodine to treat thyroid cancer increased 40 percent from 1990 to 2008 even though the risks may outweigh the benefits for some patients, particularly those with early-stage tumors.

17 Aug 2011

Thyroid Cancer News and Research

Latest Thyroid Cancer News and Research

EpiCept reports net loss of $5.4 million for third quarter 2011

Study: Melanoma survivors more likely to have new cancers

Prescription drug shortages: Endocrine Society calls for mandatory reporting by manufacturers

BUSM professor delivers Van Meter Award Lecture at 81st ATA meeting

Glitazone treatment does not cause side effects in patients with metastatic thyroid cancer

Thyroid researcher to receive ATA's John B. Stanbury Pathophysiology Medal

Thyroidectomy reduces snoring associated with obstructive sleep apnea

Researchers explore novel therapeutic approach for thyroid cancer

UCLA professor to receive ATA's Sidney H. Ingbar Distinguished Lectureship Award

New rapid method for detection of BRAF V600E gene in thyroid tissue

ATA to honor 2011 recipient of Lewis E. Braverman Lectureship Award on Oct. 29

Advanced papillary thyroid cancer patients with BRAFV600E gene mutation at higher risk

Lenvatinib may achieve partial response in thyroid, endometrial, and renal cancers

Top-line results from Exelixis' cabozantinib phase 3 trial on medullary thyroid cancer

MD Anderson professor wins 2011 Julie and Ben Rogers Award for Excellence in Prevention

Two newer Type 2 diabetes drugs could be linked to increased risk of pancreatic cancer

New diabetes drugs linked to increased risk of pancreatitis and pancreatic cancer

ATA announces five recipients of 2011 thyroid cancer research grants

Unexplained hospital factors have impact on radioactive iodine use for thyroid cancer: Study

Radioiodine being overused in thyroid cancer: Study

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Thyroid Cancer News and Research

Latest Thyroid Cancer News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in